The DOI matches its Crossref record; 36 of the 38 references it cites were found in a registry or an index.
Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus
Open accessAbstract
Objective: The Systemic Lupus International Collaborating Clinics (SLICC) group revised and validated the American College of Rheumatology (ACR) systemic lupus erythematosus (SLE) classification criteria in order to improve clinical relevance, meet stringent methodology requirements, and incorporate new knowledge regarding the immunology of SLE. Methods: The classification criteria were derived from a set of 702 expert‐rated patient scenarios. Recursive partitioning was used to derive an initial rule that was simplified and refined based on SLICC physician consensus. The SLICC group validated the classification criteria in a new validation sample of 690 new expert‐rated patient scenarios. Results: Seventeen criteria were identified. In the derivation set, the SLICC classification criteria resulted in fewer misclassifications compared with the current ACR classification criteria (49 versus 70; P = 0.0082) and had greater sensitivity (94% versus 86%; P < 0.0001) and equal specificity (92% versus 93%; P = 0.39). In the validation set, the SLICC classification criteria resulted in fewer misclassifications compared with the current ACR classification criteria (62 versus 74; P = 0.24) and had greater sensitivity (97% versus 83%; P < 0.0001) but lower specificity (84% versus 96%; P < 0.0001). Conclusion: The new SLICC classification criteria performed well in a large set of patient scenarios rated by experts. According to the SLICC rule for the classification of SLE, the patient must satisfy at least 4 criteria, including at least one clinical criterion and one immunologic criterion OR the patient must have biopsy‐proven lupus nephritis in the presence of antinuclear antibodies or anti–double‐stranded DNA antibodies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“For detection of anti-dsDNA antibodies only limited requirements for test characteristics were defined, varying from ‘increased titer’ [16,17], ‘above laboratory reference range (except for ELISA)’ [18], to ‘>90% specificity’ [19].”
From Anti-dsDNA antibodies in the classification criteria of systemic lupus erythematosus (2022) · cites this paper as [18]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The Systemic Lupus International Collaborating Clinics (SLICC) criteria published in 2012 showed that, although highly specific, the sensitivity of the ACR classification criteria for SLE was suboptimal, especially in new-onset SLE.”
From Anti-dsDNA antibodies in the classification criteria of systemic lupus erythematosus (2022) · cites this paper as [18]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Consequently, anti-dsDNA testing is an essential part of the diagnosis, classification, and management of SLE (2,3,(11)(12)(13)”
From Anti-dsDNA Testing Specificity for Systemic Lupus Erythematosus: A Systematic Review. (2022) · cites this paper as [3]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“These criteria proposed to classify only patients that have at least one immunologic criterion, overcoming SLE classification based solely on clinical manifestations.”
From Anti-dsDNA antibodies in the classification criteria of systemic lupus erythematosus (2022) · cites this paper as [18]
The cited source says what the claim attributes to it.
In the citing paper
“Accordingly, patients without the listed autoantibodies or low complement cannot be classified as having SLE.”
From Anti-dsDNA antibodies in the classification criteria of systemic lupus erythematosus (2022) · cites this paper as [18]
The cited source says what the claim attributes to it.
In the citing paper
“new classification criteria for SLE were issued in 2012 by the Systemic Lupus International Collaborating Clinics (SLICC)”
From Anti-dsDNA antibodies in the classification criteria of systemic lupus erythematosus (2022) · cites this paper as [18]
The cited source says what the claim attributes to it.
In the citing paper
“The new SLICC classification criteria contain several novelties compared to the ACR criteria [18].”
From Anti-dsDNA antibodies in the classification criteria of systemic lupus erythematosus (2022) · cites this paper as [18]
The cited source says what the claim attributes to it.
In the citing paper
“The existence of anti-dsDNA Abs in the absence of positive ANA results is thought to be a rare phenomenon that is attributed to laboratory errors [40].”
From Anti-double stranded DNA antibodies: A rational diagnostic approach in limited-resource settings (2022) · cites this paper as [40]
The cited source says what the claim attributes to it.
In the citing paper
“SLE was diagnosed and classified based on either the revised American College of Rheumatology10 or the Systemic Lupus International Collaborating Clinics classification criteria.11”
From Evaluation of different ways to identify persistent positivity of lupus anticoagulant in systemic lupus erythematosus (2020) · cites this paper as [11]
The cited source says what the claim attributes to it.
In the citing paper
“SLE patients were diagnosed according to revised ACR and SLICC criteria [23, 24].”
From Antiphospholipid patterns predict risk of thrombosis in systemic lupus erythematosus (2021) · cites this paper as [23]
The cited source says what the claim attributes to it.
In the citing paper
“Since 2012, the IgA isotype of the aPL has been accepted as a laboratory criterion for SLE in the SLICC SLE Classification Criteria [23].”
From Antiphospholipid patterns predict risk of thrombosis in systemic lupus erythematosus (2021) · cites this paper as [23]
The cited source says what the claim attributes to it.
In the citing paper
“The included studies used ACR 1982 (33), ACR 1997 (13), SLICC 2012 (3), or a combination of these classification criteria to define the SLE group.”
From Anti-dsDNA Testing Specificity for Systemic Lupus Erythematosus: A Systematic Review. (2022) · cites this paper as [3]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Classification and Regression Trees.
Gordon, A. D., Breiman, L., Friedman, J. H., Olshen, R. A., & Stone, C. J. (1984) · Biometrics · doi:10.2307/2530946 · Cited by 23,867
Classification and Regression Trees.
Ryzin, J. V., Breiman, L., Friedman, J. H., Olshen, R. A., & Stone, C. J. (1986) · Journal of the American Statistical Association · doi:10.2307/2288003 · Cited by 21,030
The 1982 revised criteria for the classification of systemic lupus erythematosus
Tan, E. M., Cohen, A. S., Fries, J. F., Masi, A. T., Mcshane, D. J., Rothfield, N. F., Schaller, J. G., Talal, N., & Winchester, R. J. (1982) · Arthritis & Rheumatism · doi:10.1002/art.1780251101 · Cited by 14,519
Hochberg, M. C. (1997) · Arthritis & Rheumatism · doi:10.1002/art.1780400928 · Cited by 11,409
Lawrence, R. C., Felson, D. T., Helmick, C. G., Arnold, L. M., Choi, H. K., Deyo, R. A., Gabriel, S. E., Hirsch, R., Hochberg, M. C., Hunder, G. G., et al. (2007) · Arthritis & Rheumatism · doi:10.1002/art.23176 · Cited by 5,599
Differential Diagnosis of Glomerular Disease: A Systematic and Inclusive Approach
Hebert, L. A., Parikh, S. M., Prosek, J. M., Nádasdy, T., & Rovin, B. H. (2013) · American Journal of Nephrology · doi:10.1159/000354390 · Cited by 4,392
Gladman, D. D., Ginzler, E. M., Goldsmith, C. H., Fortin, P. R., Liang, M. H., Sánchez‐Guerrero, J., Urowitz, M. B., Bacon, P., Bombardieri, S., Hanly, J. G., et al. (1996) · Arthritis & Rheumatism · doi:10.1002/art.1780390303 · Cited by 2,589
Self-citationNavarra, S., Guzmán, R., Gallacher, A., Hall, S., Levy, R. A., Jimenez, R., Li, E. K., Thomas, M., Kim, H., Leon, M. G., et al. (2011) · The Lancet · doi:10.1016/s0140-6736(10)61354-2 · Cited by 2,078
Self-citationEstimates of the prevalence of arthritis and other rheumatic conditions in the United States: Part I
Helmick, C. G., Felson, D. T., Lawrence, R. C., Gabriel, S. E., Hirsch, R., Kwoh, C. K., Liang, M. H., Kremers, H. M., Mayes, M. D., Merkel, P. A., et al. (2007) · Arthritis & Rheumatism · doi:10.1002/art.23177 · Cited by 2,054
The classification of glomerulonephritis in systemic lupus erythematosus revisited
Weening, J. J., ON Behalf of the International Society of Nephrology and Renal Pathology Society Working Group on the Classification Oflupus Nephritis, D’Agati, V. D., Schwartz, M. M., Seshan, S. V., Alpers, C. E., Appel, G. B., Balow, J. E., Bruijn, J. A., Cook, T. H., et al. (2004) · Kidney International · doi:10.1111/j.1523-1755.2004.00443.x · Cited by 1,649
Self-citation
Flagged first, then by citations
2 of the 38 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 301–400 of 1,011
The spectrum of kidney biopsy findings in HIV-infected patients in the modern era
Kudose, S., Santoriello, D., Bomback, A. S., Stokes, M. B., Batal, I., Markowitz, G. S., Wyatt, C. M., & D’Agati, V. D. (2020) · Kidney International · doi:10.1016/j.kint.2020.01.018 · Cited by 68
Hu, J., Wang, M., Xiao, X., Zhang, B., Xie, Q., Xu, X., Li, S., Zheng, Z., Wei, D., & Zhang, X. (2020) · Nanoscale · doi:10.1039/d0nr01308k · Cited by 67
Chen, J. Y., Wu, Y. L., Mok, M. Y., Wu, Y. J., Lintner, K. E., Wang, C., Chung, E. K., Yang, Y., Zhou, B., Wang, H., et al. (2016) · Arthritis & Rheumatology · doi:10.1002/art.39589 · Cited by 67
Biomarkers of lupus nephritis histology and flare: deciphering the relevant amidst the noise
Birmingham, D. J., Merchant, M. L., Waikar, S. S., Nagaraja, H. N., Klein, J. B., & Rovin, B. H. (2017) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfw300 · Cited by 67
Obrișcă, B., Jurubiță, R. A., Andronesi, A. G., Sorohan, B. M., Achim, C. A., Bobeica, R. L., Gherghiceanu, M., Mandache, E., & Ismail, G. (2018) · Lupus · doi:10.1177/0961203318776109 · Cited by 67
Leffers, H. C. B., Lange, T., Collins, C. E., Ulff-Møller, C. J., & Jacobsen, S. (2019) · Autoimmunity Reviews · doi:10.1016/j.autrev.2018.11.005 · Cited by 69
Self-citationDahlström, Ö., & Sjöwall, C. (2019) · Lupus · doi:10.1177/0961203319846388 · Cited by 66
Evolving story of autoantibodies in systemic lupus erythematosus
Pisetsky, D. S. (2019) · Journal of Autoimmunity · doi:10.1016/j.jaut.2019.102356 · Cited by 70
Sloan, M. A., Harwood, R., Sutton, S. R., D’Cruz, D. P., Howard, P. D., Wincup, C., Brimicombe, J. D., & Gordon, C. (2020) · Rheumatology Advances in Practice · doi:10.1093/rap/rkaa006 · Cited by 66
Self-citationGender and Ocular Manifestations of Connective Tissue Diseases and Systemic Vasculitides
Choudhary, M. M., Hajj‐Ali, R. A., & Lowder, C. Y. (2014) · Journal of Ophthalmology · doi:10.1155/2014/403042 · Cited by 66
Word2Vec inversion and traditional text classifiers for phenotyping lupus
Turner, C. A., Jacobs, A. D., Marques, C. K., Oates, J. C., Kamen, D. L., Anderson, P. E., & Obeid, J. S. (2017) · BMC Medical Informatics and Decision Making · doi:10.1186/s12911-017-0518-1 · Cited by 66
Self-citationMunroe, M. E., Young, K. A., Kamen, D. L., Guthridge, J. M., Niewold, T. B., Costenbader, K. H., Weisman, M. H., ISHIMORI, M. L., Wallace, D. J., Gilkeson, G. S., et al. (2016) · Arthritis & Rheumatology · doi:10.1002/art.40004 · Cited by 66
Self-citationSchmajuk, G., Hoyer, B. F., Aringer, M., Johnson, S. R., Daikh, D. I., Dörner, T., & the SLE classification criteria steering committee and the international SLE expert panel of the initiative (2018) · Arthritis Care & Research · doi:10.1002/acr.23503 · Cited by 65
Petri, M., Konig, M. F., Li, J., & Goldman, D. W. (2021) · Arthritis & Rheumatology · doi:10.1002/art.41621 · Cited by 70
“All patients met the revised American College of Rheumatology (ACR) classification criteria (30) or the Systemic Lupus International Collaborating Clinics (SLICC) classification criteria (31) for SLE.”
BackgroundSelf-citationDevelopment of a systemic lupus erythematosus cardiovascular risk equation
Petri, M., Barr, E. A., & Magder, L. S. (2019) · Lupus Science & Medicine · doi:10.1136/lupus-2019-000346 · Cited by 65
Self-citationSystemic lupus erythematosus as a genetic disease
Harley, I. T. W., & Sawalha, A. H. (2022) · Clinical Immunology · doi:10.1016/j.clim.2022.108953 · Cited by 68
The XIST lncRNA is a sex-specific reservoir of TLR7 ligands in SLE
Crawford, J. D., Wang, H., Trejo-Zambrano, D., Cimbro, R., Talbot, C. C., Thomas, M. A., Curran, A. M., Girgis, A. A., Schroeder, J. T., Fava, A., et al. (2023) · JCI Insight · doi:10.1172/jci.insight.169344 · Cited by 65
Self-citationCarmona-Fernandes, D., Santos, M. J., Canhão, H. M., & Fonseca, J. E. (2013) · BMC Medicine · doi:10.1186/1741-7015-11-98 · Cited by 65
Guitton, Z., Terriou, L., Lega, J., NOVE-JOSSERAND, R., Hie, M., Amoura, Z., Bussel, J. B., Hamidou, M. A., Rosenthal, É., Lioger, B., et al. (2018) · Rheumatology · doi:10.1093/rheumatology/key119 · Cited by 65
Identification and Characterization of Post-activated B Cells in Systemic Autoimmune Diseases
Weißenberg, S. Y., Szelinski, F., Schrezenmeier, E. V., Stefanski, A., Wiedemann, A., Rincón-Arévalo, H., Welle, A., Jungmann, A., Nordström, K. J. V., Walter, J., et al. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02136 · Cited by 65
Whole Exome Sequencing in Early-onset Systemic Lupus Erythematosus
Batu, E. D., Koşukçu, C., Taşkıran, E. Z., Şahin, S., Akman, S., Sözeri, B., Ünsal, E., Bilginer, Y., Kasapçopur, Ö., Alikaşifoğlu, M., et al. (2018) · The Journal of Rheumatology · doi:10.3899/jrheum.171358 · Cited by 64
New classification criteria for systemic lupus erythematosus
Aringer, M., & Petri, M. (2020) · Current Opinion in Rheumatology · doi:10.1097/bor.0000000000000740 · Cited by 67
Self-citationChance, genetics, and the heterogeneity of disease and pathogenesis in systemic lupus erythematosus
Marion, T. N., & Postlethwaite, A. E. (2014) · Seminars in Immunopathology · doi:10.1007/s00281-014-0440-x · Cited by 64
Neuropsychiatric systemic lupus erythematosus: Tools for the diagnosis
Zardi, E. M., Taccone, A., Marigliano, B., Margiotta, D. P. E., & Afeltra, A. (2014) · Autoimmunity Reviews · doi:10.1016/j.autrev.2014.04.002 · Cited by 64
Haas, M., Rastaldi, M. P., & Fervenza, F. C. (2013) · Kidney International · doi:10.1038/ki.2013.375 · Cited by 64
Amezcua-Guerra, L. M., Higuera‐Ortiz, V., García, U. G. A., Gallegos‐Nava, S., & Hübbe‐Tena, C. (2014) · Arthritis Care & Research · doi:10.1002/acr.22422 · Cited by 64
Zayat, A. S., Yusof, M. Y. M., Wakefield, R. J., Conaghan, P. G., Emery, P., & Vital, E. M. J. (2015) · Rheumatology · doi:10.1093/rheumatology/kev343 · Cited by 64
Physical activity and sedentary behavior in patients with Systemic Lupus Erythematosus
Margiotta, D. P. E., Basta, F., Dolcini, G., Batani, V., Vullo, M. L., Vernuccio, A., Navarini, L., & Afeltra, A. (2018) · PLoS ONE · doi:10.1371/journal.pone.0193728 · Cited by 65
Kim, A. H. J., Strand, V., Sen, D., Fu, Q. J., Mathis, N. L., Schmidt, M. J., Bruchas, R. R., Staten, N. R., Olson, P. K., Stiening, C. M., et al. (2018) · Arthritis & Rheumatology · doi:10.1002/art.40747 · Cited by 64
Liao, Z., Ye, Z., Xue, Z., Wu, L., Ouyang, Y., Yao, C., Cui, C., Xu, N., Ma, J., Hou, G., et al. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00975 · Cited by 64
Evaluation of remission definitions for systemic lupus erythematosus: a prospective cohort study
Golder, V., Kandane‐Rathnayake, R., Huq, M. M., Louthrenoo, W., Luo, S., Wu, Y. J., Lateef, A., Sockalingam, S., Navarra, S., Zamora, L. D., et al. (2019) · The Lancet Rheumatology · doi:10.1016/s2665-9913(19)30048-7 · Cited by 64
Sambataro, G., Sambataro, D., Torrisi, S. E., Vancheri, A., Pavone, M., Rosso, R., Schisano, M., Crimi, C., Pignataro, F. S., Fischer, A., et al. (2018) · European Respiratory Review · doi:10.1183/16000617.0139-2017 · Cited by 63
Can Complete Blood Count Picture Tell Us More About the Activity of Rheumatological Diseases?
Taha, S., Samaan, S. F., Ibrahim, R. A., Moustafa, N. M., El-Sehsah, E. M., & Youssef, M. K. (2022) · Clinical Medicine Insights Arthritis and Musculoskeletal Disorders · doi:10.1177/11795441221089182 · Cited by 63
The DNA sensors AIM2 and IFI16 are SLE autoantigens that bind neutrophil extracellular traps
Antiochos, B., Trejo-Zambrano, D., Fenaroli, P., Rosenberg, A. Z., Baer, A. N., Garg, A., Sohn, J., Li, J., Petri, M., GOLDMAN, D. W., et al. (2022) · eLife · doi:10.7554/elife.72103 · Cited by 63
Self-citationDein, E. J., Douglas, H., Petri, M., Law, G., & Timlin, H. (2019) · Cureus · doi:10.7759/cureus.4166 · Cited by 63
Self-citationTherapeutic advances in the treatment of SLE
Mohamed, A. S., Chen, Y., Wu, H., Liao, J., Cheng, B., & Lu, Q. (2019) · International Immunopharmacology · doi:10.1016/j.intimp.2019.03.010 · Cited by 63
Ruiz‐Irastorza, G., Ruiz-Estevez, B., Lazaro, E., Ruiz‐Arruza, I., Duffau, P., Cascón, M. M., Richez, C., Ugarte, A., & Blanco, P. (2019) · Autoimmunity Reviews · doi:10.1016/j.autrev.2019.102359 · Cited by 62
Self-citationFernandez‐Ruiz, R., Masson, M., Kim, M., Myers, B., Haberman, R. H., Castillo, R., Scher, J. U., Guttmann, A., Carlucci, P. M., Deonaraine, K., et al. (2020) · Arthritis & Rheumatology · doi:10.1002/art.41450 · Cited by 62
Self-citationScherlinger, M., Guillotin, V., Douchet, I., Vacher, P., Boizard-Moracchini, A., Guégan, J., Garreau, A., Merillon, N., Vermorel, A., Ribeiro, E., et al. (2021) · Science Translational Medicine · doi:10.1126/scitranslmed.abi4994 · Cited by 62
Tzioufas, A. G., Bakasis, A., Goules, A. V., Bitzogli, K., Cinoku, I. I., Chatzis, L. G., Argyropoulou, O. D., Venetsanopoulou, A. I., Mavrommati, M., Stergiou, I. Ε., et al. (2021) · Journal of Autoimmunity · doi:10.1016/j.jaut.2021.102743 · Cited by 62
The use and abuse of diagnostic/classification criteria
June, R. R., & Aggarwal, R. (2014) · Best Practice & Research Clinical Rheumatology · doi:10.1016/j.berh.2015.04.004 · Cited by 62
Zhao, J., Bai, W., Zhu, P., Zhang, X., Liu, S., Wu, L., Ma, L., Bi, L., Zuo, X., Sun, L., et al. (2016) · Lupus · doi:10.1177/0961203315625460 · Cited by 62
Disease activity patterns over time in patients with SLE: analysis of the Hopkins Lupus Cohort
Györi, N., Giannakou, I., Chatzidionysiou, K., Magder, L. S., van Vollenhoven, R., & Petri, M. (2017) · Lupus Science & Medicine · doi:10.1136/lupus-2016-000192 · Cited by 62
Self-citationMain Oral Manifestations in Immune-Mediated and Inflammatory Rheumatic Diseases
Gualtierotti, R., Marzano, A. V., Spadari, F., & Cugno, M. (2018) · Journal of Clinical Medicine · doi:10.3390/jcm8010021 · Cited by 62
Orofacial manifestations and dental management of systemic lupus erythematosus: A review
Benli, M., Batool, F., Stutz, C., Petit, C., Jung, S., & Huck, O. (2019) · Oral Diseases · doi:10.1111/odi.13271 · Cited by 62
Borrelli, S., Martire, M. S., Stölting, A., Vanden Bulcke, C., Pedrini, E., Guisset, F., Bugli, C., Yildiz, H., Pothen, L., Elands, S., et al. (2024) · Neurology Neuroimmunology & Neuroinflammation · doi:10.1212/nxi.0000000000200253 · Cited by 61
Andrade, L. E. C., Damoiseaux, J. G. M. C., Vergani, D., & Fritzler, M. J. (2022) · Journal of Translational Autoimmunity · doi:10.1016/j.jtauto.2022.100145 · Cited by 64
Björk, M., Dahlström, Ö., Wetterö, J., & Sjöwall, C. (2015) · BMC Musculoskeletal Disorders · doi:10.1186/s12891-015-0621-3 · Cited by 61
Golder, V., Kandane‐Rathnayake, R., Hoi, A. Y.-B., Huq, M. M., Louthrenoo, W., An, Y., Li, Z. G., Luo, S., Sockalingam, S., Lau, C. S., et al. (2016) · Arthritis Research & Therapy · doi:10.1186/s13075-016-1163-2 · Cited by 61
B-cell activating factor and related genetic variants in lupus related atherosclerosis
Theodorou, E. A., Nezos, A., Antypa, E. G., Ioakeimidis, D., Koutsilieris, M., Tektonidou, M. G., Moutsopoulos, H. Μ., & Mavragani, C. P. (2018) · Journal of Autoimmunity · doi:10.1016/j.jaut.2018.05.002 · Cited by 61
Host-Microbial Interactions in Systemic Lupus Erythematosus and Periodontitis
Pessoa, L. C., Aleti, G., Choudhury, S. N., Nguyen, D., Yaskell, T., Zhang, Y., Li, W., Nelson, K. E., Neto, L. L. S., Sant’Ana, A. C. P., et al. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02602 · Cited by 61
Parodis, I., Gokaraju, S., Zickert, A., Vanarsa, K., Zhang, T., Habazi, D., Botto, J., Alves, C. S., Giannopoulos, P., Larsson, A. O., et al. (2019) · Rheumatology · doi:10.1093/rheumatology/kez528 · Cited by 61
Could lymphocyte profiling be useful to diagnose systemic autoimmune diseases?
Carvajal Alegria, G., Gazeau, P., Hillion, S., Daïen, C. I., & Cornec, D. Y. K. (2017) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-017-8608-5 · Cited by 60
Tiosano, S., Farhi, A., Watad, ., Grysman, N., Stryjer, R., Amital, H., Comaneshter, D. S., Cohen, A. D., & Amital, D. (2016) · Epidemiology and Psychiatric Sciences · doi:10.1017/s2045796016000561 · Cited by 60
Díaz-Gallo, L.-M., Oke, V., Lundström, E., Elvin, K., Wu, Y. L., Eketjäll, S., Zickert, A., Gustafsson, J. T., Jönsen, A., Leonard, D., et al. (2021) · ACR Open Rheumatology · doi:10.1002/acr2.11343 · Cited by 60
Hofmann, S., Leandro, M. J., Morris, S., & Isenberg, D. A. (2013) · Lupus · doi:10.1177/0961203313497115 · Cited by 60
Self-citationPresentation of SLE in UK primary care using the Clinical Practice Research Datalink
Nightingale, A. L., Davidson, J. E., Molta, C. T., Kan, H. J., & McHugh, N. J. (2017) · Lupus Science & Medicine · doi:10.1136/lupus-2016-000172 · Cited by 60
Papadaki, E. Z., Fanouriakis, A., Kavroulakis, E., Karageorgou, D., Sidiropoulos, P. I., Bertsias, G. K., Simos, P. G., & Boumpas, D. T. (2017) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2017-212285 · Cited by 60
Ünlü, O., Erkan, D., Barbhaiya, M., ANDRADE, D. C. O. D., Nascimento, I. S., Rosa, R. F., Banzato, A., Pengo, V., Ugarte, A., Gerosa, M., et al. (2018) · Arthritis Care & Research · doi:10.1002/acr.23584 · Cited by 60
Self-citationAutoantibodies in Systemic Lupus Erythematosus Target Mitochondrial RNA
Becker, Y., Marcoux, G., Allaeys, I., Julien, A.-S., Loignon, R.-C., Benk-Fortin, H., Rollet-Labelle, E., Rauch, J., Fortin, P. R., & Boilard, E. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01026 · Cited by 59
“Other outcome variables included arterial and venous thrombotic event ever in the past and presence of lupus nephritis according to the presence or absence of the renal item of the SLICC Classification criteria for SLE (53).”
BackgroundSelf-citationRuiz-García, R., Serrano, M., Ángel Martínez-Flores, J., Mora, S., Morillas, L., Martín-Mola, M. Á., Morales, J. M., Paz-Artal, E., & Serrano, A. (2014) · Journal of Immunology Research · doi:10.1155/2014/704395 · Cited by 59
A Novel Human Systemic Lupus Erythematosus Model in Humanised Mice
Gunawan, M., Her, Z., Liu, M., Tan, S. Y., Chan, X. Y., Tan, W. W. S., Dharmaraaja, S., Fan, Y., Ong, C. B., Loh, E., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-16999-7 · Cited by 59
A Novel Serum tsRNA for Diagnosis and Prediction of Nephritis in SLE
Yang, P., Zhang, X., Chen, S., Tao, Y., Ning, M., Zhu, Y., Liang, J. F., Kong, W., Shi, B., Li, Z., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.735105 · Cited by 59
Clinical patterns of disease: From early systemic lupus erythematosus to late-onset disease
Piga, M., Tselios, K., Viveiros, L., Chessa, E., Neves, A., Urowitz, M. B., & Isenberg, D. A. (2023) · Best Practice & Research Clinical Rheumatology · doi:10.1016/j.berh.2024.101938 · Cited by 59
Self-citationClinical Significance of IgA Anti-Cardiolipin and IgA Anti-β2Glycoprotein I Antibodies
Andréoli, L., Fredi, M., Nalli, C., Piantoni, S., Reggia, R., Dall’Ara, F., Franceschini, F., & Tincani, A. (2013) · Current Rheumatology Reports · doi:10.1007/s11926-013-0343-1 · Cited by 59
Understanding mechanisms of hypertension in systemic lupus erythematosus
Taylor, E. B., & Ryan, M. J. (2016) · Therapeutic Advances in Cardiovascular Disease · doi:10.1177/1753944716637807 · Cited by 59
Neurological Disease in Lupus: Toward a Personalized Medicine Approach
McGlasson, S. L., Wiseman, S. J., Wardlaw, J. M., Dhaun, N., & Hunt, D. P. J. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01146 · Cited by 59
The Incidence and Prevalence of Adult Primary Sjögren's Syndrome in New York County
Izmirly, P., Buyon, J. P., Wan, I., Belmont, M. H., Sahl, S., Salmon, J. E., Askanase, A., Bathon, J. M., Geraldino-Pardilla, L. B., Ali, Y., et al. (2018) · Arthritis Care & Research · doi:10.1002/acr.23707 · Cited by 59
Self-citationGastrointestinal Manifestations of Rheumatological Diseases
Kröner, P. T., Tolaymat, O., Bowman, A. W., Abril, A., & Lacy, B. E. (2019) · The American Journal of Gastroenterology · doi:10.14309/ajg.0000000000000260 · Cited by 59
Associated clinical factors for serious infections in patients with systemic lupus erythematosus
Jung, J., Yoon, D., Choi, Y. H., Kim, H., & Suh, C. (2019) · Scientific Reports · doi:10.1038/s41598-019-46039-5 · Cited by 59
Leehan, K. M., Pezant, N. P., Rasmussen, A., Grundahl, K., Moore, J. S., Radfar, L., Lewis, D. M., Stone, D. U., Lessard, C. J., Rhodus, N. L., et al. (2018) · PubMed · Cited by 59
Antinuclear antibodies in infectious diseases
Im, J. H., Chung, M., Park, Y. K., Kwon, H. Y., Baek, J. H., Lee, S. Y., & Lee, J. S. (2019) · Scandinavian Journal of Infectious Diseases · doi:10.1080/23744235.2019.1690676 · Cited by 59
Using genetics to prioritize diagnoses for rheumatology outpatients with inflammatory arthritis
Knevel, R., le Cessie, S., Terao, C., Slowikowski, K., Cui, J., Huizinga, T. W. J., Costenbader, K. H., Liao, K. P., Karlson, E. W., & Raychaudhuri, S. (2020) · Science Translational Medicine · doi:10.1126/scitranslmed.aay1548 · Cited by 59
Johnson, S. R., Brinks, R., Costenbader, K. H., Daikh, D., Mosca, M., Ramsey‐Goldman, R., Smolen, J. S., Wofsy, D., Boumpas, D. T., Kamen, D. L., et al. (2020) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2020-217162 · Cited by 59
Self-citationLupus eritematoso sistémico 2020
Narváez, J. (2020) · Medicina Clínica · doi:10.1016/j.medcli.2020.05.009 · Cited by 63
Boeke, A., Pullen, B., Coppes, L., Medina, M., & Cooper, J. J. (2018) · Psychosomatics · doi:10.1016/j.psym.2018.06.007 · Cited by 58
Sex hormones drive changes in lipoprotein metabolism
Robinson, G., Peng, J., Peckham, H., Radziszewska, A., Butler, G. E., Pineda‐Torra, I., Jury, E. C., & Ciurtin, C. (2021) · iScience · doi:10.1016/j.isci.2021.103257 · Cited by 59
Choi, M. Y., & Costenbader, K. H. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.890522 · Cited by 58
Kuhn, A., Wenzel, J., & Bijl, M. (2015) · Seminars in Immunopathology · doi:10.1007/s00281-015-0550-0 · Cited by 58
Sarah El-Rabbat, M., Mahmoud, N. K., & Gheita, T. A. (2017) · Reumatología Clínica · doi:10.1016/j.reuma.2017.02.008 · Cited by 58
Biomarkers in connective tissue diseases
Jog, N. R., & James, J. A. (2017) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2017.10.003 · Cited by 58
Ağın, A., Kadayıfçılar, S., Sönmez, H. E., Baytaroğlu, A., Demir, S., Sağ, E., Özen, S., & Eldem, B. M. (2018) · Lupus · doi:10.1177/0961203318814196 · Cited by 58
Johnson, S. R., Khanna, D., Daikh, D., Cervera, R., Costedoat-Chalumeau, N., Gladman, D. D., Hahn, B. H., Hiepe, F., Sánchez‐Guerrero, J., Massarotti, E. M., et al. (2018) · The Journal of Rheumatology · doi:10.3899/jrheum.180478 · Cited by 57
Self-citationGomes, M. F., Mardones, C., Xipell, M., Blasco, M., Solé, M., Espinosa, G., García‐Herrera, A., Cervera, R., & Quintana, L. F. (2021) · Journal of Nephrology · doi:10.1007/s40620-021-01007-z · Cited by 57
Recent advances in understanding the genetic basis of systemic lupus erythematosus
Ha, E., Bae, S., & Kim, K.-W. (2021) · Seminars in Immunopathology · doi:10.1007/s00281-021-00900-w · Cited by 57
Self-citationThe standardisation of uveitis nomenclature ( SUN ) project
Jabs, D. A., McCluskey, P., Palestine, A. G., Thorne, J. E., & Gr, T. S. O. U. N. W. (2022) · Clinical and Experimental Ophthalmology · doi:10.1111/ceo.14175 · Cited by 57
Webber, D., Cao, J., Domínguez, D., Gladman, D. D., Levy, D. M., Ng, L., Paterson, A. D., Touma, Z., Urowitz, M. B., Wither, J., et al. (2019) · Rheumatology · doi:10.1093/rheumatology/kez220 · Cited by 57
Self-citationVerdú, R. C., Pego‐Reigosa, J. M., Seoane‐Mato, D., Valle, M. M., Sánchez, D. P., Moreno, M. J., González, M. M., de Buruaga, J. A. S., Onaindia, I. U., Cáceres, B. A. B., et al. (2019) · Rheumatology · doi:10.1093/rheumatology/kez668 · Cited by 57
IL-17 sustains the plasma cell response via p38-mediated Bcl-xL RNA stability in lupus pathogenesis
Ma, K., Du, W., Xiao, F., Han, M., Huang, E., Peng, N., Tang, Y., Deng, C., Liu, L., Chen, Y., et al. (2020) · Cellular and Molecular Immunology · doi:10.1038/s41423-020-00540-4 · Cited by 56
Advances in the care of children with lupus nephritis
Wenderfer, S. E., Ruth, N. M., & Brunner, H. I. (2016) · Pediatric Research · doi:10.1038/pr.2016.247 · Cited by 56
Cell-bound complement activation products in SLE
Ramsey‐Goldman, R., Li, J., Dervieux, T., & Alexander, R. V. (2017) · Lupus Science & Medicine · doi:10.1136/lupus-2017-000236 · Cited by 56
Self-citationSLE and Serum Complement: Causative, Concomitant or Coincidental?
Sandhu, V. K., & Quan, M. (2017) · The Open Rheumatology Journal · doi:10.2174/1874312901711010113 · Cited by 56
Quiroz, E. N., Pacheco-Lugo, L., Quiroz, R. N., Lorenzi, H., España-Puccini, P., Díaz-Olmos, Y., Almendrales, L., Olave-Jaller, V., González-Torres, H. J., Pérez, A. D., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0187973 · Cited by 56
Frodlund, M., Wetterö, J., Dahle, C., Dahlström, Ö., Skogh, T., Rönnelid, J., & Sjöwall, C. (2019) · Clinical & Experimental Immunology · doi:10.1111/cei.13402 · Cited by 56
Nikolopoulos, D., Kostopoulou, M., Pieta, A., Karageorgas, T., Tseronis, D. D., Chavatza, K., Flouda, S., Rapsomaniki, P., Banos, A., Kremasmenou, E., et al. (2020) · Lupus · doi:10.1177/0961203320908932 · Cited by 56
Koelmeyer, R., Nim, H. T., Nikpour, M., Sun, Y. B., Kao, A. H., Guenther, O., Morand, E. F., & Hoi, A. Y.-B. (2020) · Lupus Science & Medicine · doi:10.1136/lupus-2019-000372 · Cited by 56
Longitudinal Immune Cell Profiling in Patients With Early Systemic Lupus Erythematosus
Sasaki, T., Bracero, S., Keegan, J., Chen, L., Cao, Y., Stevens, E. F., Qu, Y., Wang, G., Nguyen, J. P., Sparks, J. A., et al. (2022) · Arthritis & Rheumatology · doi:10.1002/art.42248 · Cited by 55
Chen, R., Fu, R., Lin, Z., Huang, C., & Huang, W. (2022) · Lupus · doi:10.1177/09612033221141253 · Cited by 55
A20 Haploinsufficiency: A Systematic Review of 177 Cases
Elhani, I., Riller, Q., Boursier, G., Hentgen, V., Rieux‐Laucat, F., & Georgin‐Lavialle, S. (2023) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2023.12.007 · Cited by 55
Neoself-antigens are the primary target for autoreactive T cells in human lupus
Mori, S., Kohyama, M., Yasumizu, Y., Tada, A., Tanzawa, K., Shishido, T., Kishida, K., Jin, H., Nishide, M., Kawada, S., et al. (2024) · Cell · doi:10.1016/j.cell.2024.08.025 · Cited by 55
Metadata
- Authors
- Petri, M., Orbai, A., Alarcón, G. S., Gordon, C., Merrill, J. T., Fortin, P. R., Bruce, I. N., Isenberg, D., Wallace, D. J., Nived, O., Sturfelt, G., Ramsey‐Goldman, R., Bae, S., Hanly, J. G., Sánchez‐Guerrero, J., Clarke, A., Aranow, C., Manzi, S., Urowitz, M., Gladman, D., Kalunian, K., Costner, M., Werth, V. P., Zoma, A., Bernatsky, S., Ruiz‐Irastorza, G., Khamashta, M. A., Jacobsen, S., Buyon, J. P., Maddison, P., Dooley, M. A., van Vollenhoven, R. F., Ginzler, E., Stoll, T., Peschken, C., Jorizzo, J. L., Callen, J. P., Lim, S. S., Fessler, B. J., Inanc, M., Kamen, D. L., Rahman, A., Steinsson, K., Franks, A. G., Sigler, L., Hameed, S., Fang, H., Pham, N., Brey, R., Weisman, M. H., McGwin, G., & Magder, L. S.
- Affiliations
- Johns Hopkins University (US)
- University of Alabama at Birmingham (US)
- University of Birmingham (GB)
- Oklahoma Medical Research Foundation (US)
- Centre hospitalier universitaire de Québec (CA)
- Manchester Academic Health Science Centre (GB)
- Cedars-Sinai Medical Center (US)
- Skåne University Hospital (SE)
- Northwestern University (US)
- Dalhousie University (CA)
- Mount Sinai Hospital (CA)
- Feinstein Institute for Medical Research (US)
- Toronto Western Hospital (CA)
- University of California San Diego (US)
- University of Pennsylvania (US)
- Hairmyres Hospital (GB)
- McGill University Health Centre (CA)
- University of the Basque Country (ES)
- St Thomas' Hospital (GB)
- New York University (US)
- Ysbyty Gwynedd Hospital NHS Trust (GB)
- University of North Carolina at Chapel Hill (US)
- Karolinska University Hospital (SE)
- SUNY Downstate Health Sciences University (US)
- Spitäler Schaffhausen (CH)
- Atrium Health Wake Forest Baptist (US)
- University of Louisville (US)
- Emory University (US)
- Medical University of South Carolina (US)
- University of Maryland, Baltimore (US)
- Corresponding author
- Petri, Michelle
- ORCID
- Petri, Michelle
- Orbai, Ana‐Maria
- Alarcón, Graciela S.
- Gordon, Caroline
- Merrill, Joan T.
- Fortin, Paul R.
- Bruce, Ian N.
- Isenberg, David
- Wallace, Daniel J.
- Nived, Ola
- Ramsey‐Goldman, Rosalind
- Bae, Sang‐Cheol
- Hanly, John G.
- Sánchez‐Guerrero, Jorge
- Clarke, Ann
- Aranow, Cynthia
- Manzi, Susan
- Urowitz, Murray
- Gladman, Dafna
- Kalunian, Kenneth
- Werth, Victoria P.
- Bernatsky, Sasha
- Ruiz‐Irastorza, Guillermo
- Khamashta, Munther A.
- Buyon, Jill P.
- Maddison, Peter
- Ginzler, Ellen
- Stoll, Thomas
- Peschken, Christine
- Jorizzo, Joseph L.
- Callen, Jeffrey P.
- Lim, S. Sam
- Kamen, Diane L.
- Rahman, Anisur
- Franks, Andrew G.
- Fang, Hong
- Brey, Robin
- Weisman, Michael H.
- McGwin, Gerald
- Magder, Laurence S.
- Venue
- Arthritis & Rheumatism
- Publisher
- Wiley
- Published
- 2012-07-27
- Volume
- 64
- Issue
- 8
- Pages
- 2677-2686
- ISSN
- 0004-3591 (ISSN-L)
- 1529-0131
- PMC
- PMC3409311
- OpenAlex
- W2159860161
- Cited by
- 5,322
- References
- 38
- Citations by year
- 2026: 322 · 2025: 421 · 2024: 454 · 2023: 507 · 2022: 550 · 2021: 572 · 2020: 524 · 2019: 450 · 2018: 415 · 2017: 343 · 2016: 282 · 2015: 220 · 2014: 163 · 2013: 78 · 2012: 13
- FWCI
- 116.60
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- Arthritis & Rheumatism (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Lund University Publications (Lund University) (submittedVersion)
- SUNY Digital Repository Support (State University of New York System) (submittedVersion, cc-by-nc-nd)
- University of Birmingham Research Portal (University of Birmingham) (submittedVersion)
- Research at the University of Copenhagen (University of Copenhagen) (submittedVersion)
- Research Explorer (The University of Manchester) (submittedVersion)
- Hirsla (Landspítali University Hospital) (submittedVersion)
- Funders
- National Institutes of Health (UL1TR000150)
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (R01AR043727, U01AR051871, T32AR048522)
- National Center for Advancing Translational Sciences
- Topics
- Health Sciences › Medicine › Rheumatology › Systemic Lupus Erythematosus Research
- Health Sciences › Medicine › Rheumatology › Systemic Sclerosis and Related Diseases
- Health Sciences › Medicine › Rheumatology › Vasculitis and related conditions
- Keywords
- systemic lupus erythematosus, classification criteria, SLICC criteria, ACR classification criteria, diagnostic accuracy, sensitivity and specificity, recursive partitioning, lupus nephritis, antinuclear antibodies, anti-dsDNA antibodies
- MeSH terms
- Antibodies, Anti-Idiotypic, Antibodies, Antinuclear, Biopsy, DNA, Humans, International Agencies, Lupus Erythematosus, Systemic, Lupus Nephritis, Sensitivity and Specificity
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
